Schering Hepatitis Innovations
About Hepatitis
Treatment for Hepatitis
For Health Care Professionals
Product Inserts
Navigation Bottom
Take Our Survey

Protecting your personal information is very important to Schering Hepatitis Innovations. Please review our Privacy Policy to learn more about what we will and won�t do with the information you provide.
  1. Have you or someone you know been diagnosed with chronic viral hepatitis B or C?

  2. Yes
    No

  3. What is your relationship to the person with chronic viral hepatitis B or C?

  4. Self
    Family Member
    Friend
    Other

  5. What is your/their age? Years:

  6. <30
    30-39
    40-49
    50-59
    60-69
    70+

  7. How long ago were you/they diagnosed with chronic viral hepatitis?

  8. 1-6 Months
    7-12 Months
    2-3 Years
    4-5 Years
    6+ Years

  9. With what type of chronic viral hepatitis were you/they diagnosed?

  10. Hepatitis B
    Hepatitis C

  11. How did you/they come to know about the chronic viral hepatitis condition?

  12. Routine physical
    Blood bank
    Symptoms
    Other

  13. Were you/they offered alfa-interferon treatment?

  14. Yes
    No

  15. If treatment was refused, what was the primary reason? (Check one only.)

  16. Treatment-related side effects
    Low effectiveness
    Cost
    Self-injection drug administration
    Other

  17. What was the specialty of the physician who diagnosed you/them with chronic viral hepatitis B or C?

  18. Gastroenterologist
    Hepatologist
    Internist
    Family Practitioner
    Infectious Disease
    Other

  19. What medications have you/they had or are currently taking to treat chronic viral hepatitis? (Please check all that apply.)

  20. PEG-INTRON® (peginterferon alfa-2b) Powder for
         Injection
    INTRON® A (Interferon alfa-2b, recombinant) for
         Injection
    REBETRON® Combination Therapy containing
         REBETOL® (Ribavirin, USP) Capsules and INTRON® A
         (Interferon alfa-2b, recombinant) Injection
    Roferon A®* (interferon alfa 2a)
    Infergen®+ (interferon alfacon-1)
    Not taken medication
    Don't know
    Other
    *Roferon A® is a registered trademark of Hoffman-La Roche.
    +Infergen® is a registered trademark of Amgen, Inc.


  21. Have you/they had to discontinue treatment for any reason?

  22. Yes
    No

    If yes, what was the reason?
    Treatment-related side effects
    Cost
    Inconvenience
    Lack of response to treatment
    other

  23. How many INTRON® A prescriptions have you/they filled in the last year?

  24. 0
    1-3
    4-6
    7-12
    13+

  25. How many REBETRON® Combination Therapy prescriptions have you/they filled in the last year?

  26. 0
    1-3
    4-6
    7-12
    13+

  27. Are you/they:

  28. Male
    Female

  29. How did you hear about this Web site?

  30. Television
    Magazine
    Newspaper
    Mail
    Information from the doctor's office
    Electronic search
    Word of mouth

  31. How helpful do you find this Web site?
    Very helpful
    Somewhat helpful
    Not very helpful
    No help at all

    Please explain:

   


Return to Top

Terms and ConditionsPrivacy Policy
Copyright © 2002, Schering Corporation, Kenilworth, NJ 07033. All rights reserved.
Schering Hepatitis Innovations Home Search Site Map Glossary